Public Employees Retirement System of Ohio Has $2.42 Million Holdings in Chemed Corporation $CHE

Public Employees Retirement System of Ohio cut its position in Chemed Corporation (NYSE:CHE) by 8.7% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,967 shares of the company’s stock after selling 476 shares during the period. Public Employees Retirement System of Ohio’s holdings in Chemed were worth $2,419,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CHE. Alpine Bank Wealth Management bought a new position in shares of Chemed in the first quarter worth about $29,000. HM Payson & Co. bought a new position in shares of Chemed in the first quarter worth about $30,000. SVB Wealth LLC bought a new position in shares of Chemed in the first quarter worth about $30,000. Whipplewood Advisors LLC raised its stake in shares of Chemed by 54.5% in the first quarter. Whipplewood Advisors LLC now owns 51 shares of the company’s stock worth $31,000 after acquiring an additional 18 shares during the last quarter. Finally, WPG Advisers LLC bought a new position in shares of Chemed in the first quarter worth about $32,000. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Chemed

In related news, EVP Nicholas Michael Westfall sold 10,012 shares of the stock in a transaction on Monday, August 4th. The shares were sold at an average price of $421.91, for a total transaction of $4,224,162.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Patrick P. Grace sold 150 shares of the stock in a transaction on Tuesday, September 9th. The stock was sold at an average price of $463.39, for a total transaction of $69,508.50. Following the transaction, the director owned 3,397 shares of the company’s stock, valued at $1,574,135.83. The trade was a 4.23% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 13,162 shares of company stock worth $5,677,511. Company insiders own 3.29% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on CHE shares. Oppenheimer dropped their target price on shares of Chemed from $650.00 to $580.00 and set an “outperform” rating for the company in a research note on Thursday, July 31st. Wall Street Zen downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research note on Saturday, July 5th. Royal Bank Of Canada dropped their target price on shares of Chemed from $640.00 to $589.00 and set an “outperform” rating for the company in a research note on Thursday, July 31st. Jefferies Financial Group raised shares of Chemed from a “hold” rating to a “buy” rating and boosted their price target for the stock from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Finally, Bank of America dropped their price target on shares of Chemed from $610.00 to $595.00 and set a “buy” rating for the company in a research note on Wednesday, September 10th. Four equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock presently has an average rating of “Buy” and an average target price of $578.50.

Chemed Stock Performance

Shares of NYSE:CHE opened at $441.44 on Friday. Chemed Corporation has a 52 week low of $408.42 and a 52 week high of $623.60. The company has a market capitalization of $6.43 billion, a PE ratio of 22.70, a PEG ratio of 2.56 and a beta of 0.43. The company has a 50 day moving average price of $449.24 and a two-hundred day moving average price of $517.53.

Chemed (NYSE:CHE) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $4.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.02 by ($1.75). Chemed had a return on equity of 25.83% and a net margin of 11.56%.The company had revenue of $618.80 million for the quarter, compared to the consensus estimate of $650.60 million. During the same period in the prior year, the company earned $5.47 EPS. The firm’s revenue was up 3.8% on a year-over-year basis. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. On average, sell-side analysts forecast that Chemed Corporation will post 21.43 earnings per share for the current year.

Chemed Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Monday, August 11th were issued a dividend of $0.60 per share. The ex-dividend date was Monday, August 11th. This is a positive change from Chemed’s previous quarterly dividend of $0.50. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed’s dividend payout ratio is currently 12.34%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.